AK127
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AK127, covering 2025-03-03 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]